NCT03594344 Additional Hyperbaric Oxygen After Lower Extremity Amputation
| NCT ID | NCT03594344 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Oslo University Hospital |
| Condition | Diabetes Mellitus |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2018-07-04 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2018-07-04 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study evaluates the effect of additional hyperbaric oxygen therapy after lower extremity amputation. The patients will be randomized after amputation to either a treatment group receiving hyperbaric oxygen therapy, or control group.
Eligibility Criteria
Inclusion Criteria: * Lower extremity amputation because of chronic wound, osteomyelitis, ischemia, necrosis. * Fit to receive hyperbaric oxygen therapy determined by an anesthesiologist/Hyperbaric Medicine Physician. * Able to cooperate and follow up appointments * Included within 7 days after final surgery Exclusion Criteria: * Not fulfilling inclusion criteria * Pregnancy * Dementia
Contact & Investigator
Jonas V Rydinge, MD
PRINCIPAL INVESTIGATOR
Ullevål University Hospital, orthopedic department
Frequently Asked Questions
Who can join the NCT03594344 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Diabetes Mellitus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03594344 currently recruiting?
Yes, NCT03594344 is actively recruiting participants. Contact the research team at jonryd@ous-hf.no for enrollment information.
Where is the NCT03594344 trial being conducted?
This trial is being conducted at Oslo, Norway, Oslo, Norway.
Who is sponsoring the NCT03594344 clinical trial?
NCT03594344 is sponsored by Oslo University Hospital. The principal investigator is Jonas V Rydinge, MD at Ullevål University Hospital, orthopedic department. The trial plans to enroll 120 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.